Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00064467 · ClinicalTrials.gov registry record · Phase 3
Lethargic Depression Study
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 268
- Enrollment target
NCT00064467 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 268 participants.
The verdict
NCT00064467, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 268 participants
- Enrollment target
Study Summary
This is a study of Major Depressive Disorder (MDD) in patients with decreased energy, pleasure and interests.
Interventions
- DRUG Extended-release bupropion (HCl)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2003-06 |
| Est. Completion | 2005-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00064467
The ClinicalTrials.gov registry entry for NCT00064467 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Extended-release bupropion (HCl) is the first listed.
NCT00064467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00064467 about?
NCT00064467 is a clinical study titled "Lethargic Depression Study". This is a study of Major Depressive Disorder (MDD) in patients with decreased energy, pleasure and interests.
What is the current status of trial NCT00064467?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 268 participants. The study started on 2003-06. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00064467?
The interventions under investigation include: Extended-release bupropion (HCl) (DRUG).
Who is sponsoring clinical trial NCT00064467?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.